Clinical Trial Update: MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update of MOv19-BBz CAR T cells targeting aFR-expressing recurrent high-grade serous ovarian, fallopian tube, or primary peritoneal cancer. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• MOv19-BBz CAR T Cells (MOv19-BBz CAR T cells)

Snippet

Sponsor: University of Pennsylvania | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 1 | Status: TERMINATED | Results posted: 2025-03-26